CClinicalTrials.gg
CompletedNCT06642337NEPOT-IDAUpdated Sep 30, 2026

Nutritional Educational Program On Therapy in Iron Deficiency Anemia

An interventional study of Educational program in Iron Deficiency Anemia (IDA), Nutrition Disorders and Growth Retardation, sponsored by Hawler Medical University. Completed at 1 site in Iraq. Open to participants aged 1 Year to 5 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Hawler Medical University · Not applicable, Interventional, and Supportive care

Updated Sep 30, 2026Now CompletedInterventions changed+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Non-randomized
Ages
1 Year to 5 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether a Nutritional Educational Program for caregivers can improve their knowledge and performance in managing iron deficiency anemia (IDA) in children, compared to oral iron therapy alone. The study focuses on children with IDA, particularly in [age range 1-5 years], and aims to determine if combining nutritional education with oral iron therapy has a greater impact on improving hemoglobin levels than iron therapy alone.

The main questions it aims to answer are:

  1. Does caregiver education improve children's hemoglobin levels more effectively than oral iron therapy alone?
  2. Does nutritional education improve caregiver knowledge and practices regarding iron-rich diets? Researchers will compare children who receive both caregiver education and oral iron therapy to those receiving only oral iron therapy to assess differences in hemoglobin levels.

Participants will:

Receive oral iron supplements. Caregivers will participate in educational sessions on dietary strategies to manage IDA.

Read the detailed description

This clinical trial aims to explore the effectiveness of a Nutritional Educational Program for caregivers, in combination with oral iron therapy, on improving hemoglobin levels in children with iron deficiency anemia (IDA). Iron deficiency is a leading cause of anemia in children, and oral iron supplementation is the standard treatment. However, dietary habits and caregiver knowledge also play a significant role in managing this condition. This study will evaluate whether equipping caregivers with nutritional education enhances the outcomes of oral iron therapy.

The study will involve two groups of children with confirmed iron deficiency anemia:

Intervention Group: Children receiving oral iron therapy combined with a structured Nutritional Educational Program for their caregivers. The educational program will cover:

Understanding iron deficiency anemia and its effects on child health. Identification of iron-rich foods and dietary strategies to enhance iron absorption (e.g., vitamin C-rich foods).

Avoidance of dietary inhibitors that reduce iron absorption (e.g., calcium-rich foods and tea during meals).

Guidance on meal preparation and frequency to optimize iron intake. Control Group: Children receiving only oral iron therapy without the nutritional education component.

The primary outcome will be the change in hemoglobin levels over a specified period. Secondary outcomes will include caregivers' knowledge and performance, measured through pre- and post-intervention questionnaires, as well as adherence to the treatment regimen and dietary recommendations.

Participants will attend follow-up visits where hemoglobin levels will be monitored, and caregivers will be assessed for their understanding and application of the nutritional guidance provided. Data on the children's dietary intake will also be collected and analyzed.

This trial aims to determine if caregiver-focused nutritional education improves the management of IDA more effectively than iron therapy alone, potentially leading to better long-term health outcomes in children.

02

Conditions studied

  • Iron Deficiency Anemia (IDA)
  • Nutrition Disorders
  • Growth Retardation

Keywords

  • Iron Deficiency Anemia
  • Pediatric Anemia
  • Oral Iron Therapy
  • Nutritional Education
  • Caregiver Knowledge
  • Hemoglobin Levels
03

In context

Anemia, Iron-Deficiency

644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.

This study's enrollment of 180 is above the median of 100 across 503 interventional studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

Hawler Medical University is the lead sponsor of 56 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Children aged 1 year to 5 years.
  2. Confirmed diagnosis of iron deficiency anemia (hemoglobin \<11 g/dL).
  3. A responsible caregiver must provide written informed consent for participation.
  4. No acute or chronic illnesses affecting study outcomes.
  5. Reside in the study area with access to participating healthcare facilities.

Exclusion criteria

Exclusion Criteria:

  1. Any child who has received iron supplementation or blood transfusions in the past 3 months.
  2. Diagnosis of any anemia other than iron deficiency anemia.
  3. Known severe allergic reactions to iron supplements.
  4. Caregivers unable or unwilling to comply with study protocols.
  5. Current use of medications affecting iron metabolism.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (actual)

Study arms

  • Experimental
    Nutritional Education

    Participants in this arm will receive a Nutritional Educational Program designed specifically for caregivers of children diagnosed with iron deficiency anemia. This program includes a series of interactive sessions that focus on the following key components: Understanding Iron Deficiency Anemia: Caregivers will learn about the causes, symptoms, and health implications of iron deficiency anemia in children. Nutritional Education: The program will provide comprehensive information on identifying and incorporating iron-rich foods into the child's diet, including meats, leafy greens, legumes, and fortified cereals. Enhancing Iron Absorption: Caregivers will be educated on dietary strategies to improve iron absorption, such as consuming vitamin C-rich foods alongside iron sources and avoiding inhibitors like calcium and certain beverages during meals. Meal Planning and Preparation: Practical guidance will be given on how to effectively plan and prepare meals that are rich in iron

    Other: Educational program

  • Experimental
    Oral Iron Therapy

    Participants in this arm will receive oral iron therapy as the standard treatment for iron deficiency anemia. The intervention will include the following components: Prescription of Oral Iron Supplement: Participants will be prescribed a specific oral iron formulation, such as ferrous sulfate, ferrous fumarate, or ferrous gluconate, according to established clinical guidelines tailored to the child's age and severity of anemia. Dosage and Administration: Caregivers will receive clear instructions regarding the appropriate dosage, which will be determined based on the child's weight and medical needs. Administration guidelines will include taking the iron supplement on an empty stomach for optimal absorption, unless otherwise advised by a healthcare provider. Monitoring of Adherence and Response: Caregivers will be instructed on the importance of adherence to the prescribed regimen, with scheduled follow-up visits to monitor hemoglobin levels and assess the child's overall health

    Other: Educational program

  • Experimental
    Oral Iron Therapy + Nutritional Education

    Both above information Oral Iron Therapy + Nutritional Education

    Other: Educational program

Interventions

  • OtherEducational program

    The Nutritional Education Program is a structured intervention designed to enhance caregivers' understanding of nutrition and improve dietary practices for children suffering from iron deficiency anemia. The program comprises three weeks person by person interview lasting 25 Mins each, focusing on essential topics such as the importance of iron in child development, identifying and preparing iron-rich foods, and practical meal planning strategies. Participants will engage in hands-on cooking demonstrations and receive educational materials, including recipe cards and meal planning tools, to support their learning. Knowledge assessments will be conducted at the beginning and end of the program to measure improvements in caregivers' nutritional knowledge.

    Also known as: Nutritional Education Program

06

What researchers measure

Primary outcomes

  1. Change in Hemoglobin Levels

    His outcome measure aims to assess the difference in hemoglobin levels in children diagnosed with iron deficiency anemia at the beginning of the study compared to their levels at the end of the intervention. The study will compare the effectiveness of oral iron therapy alone versus oral iron therapy combined with a Nutritional Educational Program provided to caregivers. Hemoglobin levels will be evaluated through blood tests, providing a quantitative assessment of the interventions' impact on anemia.

    Time frame: 3 months (Measured at baseline and at the conclusion of the study).

Secondary outcomes

  1. Improvement in Caregivers' Knowledge of Iron-Rich Foods

    This measure will evaluate the change in caregivers' knowledge regarding dietary management of iron deficiency anemia before and after the Nutritional Educational Program. The assessment will be conducted using a validated questionnaire that gauges understanding of iron-rich foods, dietary sources, and practices that enhance iron absorption.

    Time frame: Before the educational intervention and 3 months post-intervention.

07

Study locations

1 site
  • Hawler Medical University/College of nursing
    Erbil, Kurdistan Region, Iraq 44001, Iraq
08

References and documents

Publications

  • Chandra J, Dewan P, Kumar P, Mahajan A, Singh P, Dhingra B, Radhakrishnan N, Sharma R, Manglani M, Rawat AK, Gupta P, Gomber S, Bhat S, Gaikwad P, Elizabeth KE, Bansal D, Dubey AP, Shah N, Kini P, Trehan A, Datta K, Basavraja GV, Saxena V, Kumar RR. Diagnosis, Treatment and Prevention of Nutritional Anemia in Children: Recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics. Indian Pediatr. 2022 Oct 15;59(10):782-801. PubMed 36263494 ↗
  • da Silva Lopes K, Yamaji N, Rahman MO, Suto M, Takemoto Y, Garcia-Casal MN, Ota E. Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews. Cochrane Database Syst Rev. 2021 Sep 26;9(9):CD013092. doi: 10.1002/14651858.CD013092.pub2. PubMed 34564844 ↗

Individual participant data

Plan to share: No

09

Updates

2 registry updates since Sep 25, 2026
Status
Active, not recruiting→Completed
changed Sep 25, 2026
Primary completion
Sep 1, 2026→Sep 15, 2026 (actual)
Sep 25, 2026
Study completion
Nov 1, 2026→Sep 22, 2026 (actual)
Sep 25, 2026
Also revised
interventions
Show all 2 updates
  1. Sep 30, 2026
    Interventions Arms or interventions changed
  2. Sep 25, 2026
    Active, not recruiting→Completed
    Primary completion Sep 1, 2026→Sep 15, 2026 (now actual)
    Study completion Nov 1, 2026→Sep 22, 2026 (now actual)
    + 2 other changes: verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06642337
Lead sponsor
Hawler Medical University
Responsible party
AMANJ YASSIN HAMAD AMIN (MSc In Pediatric Nursing, Hawler Medical University) — Principal investigator
First posted
Oct 15, 2024
Start date
Feb 1, 2025
Primary completion
Sep 15, 2026
Completion
Sep 22, 2026
Last update
Sep 30, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion